Long-term efficacy and safety of once-daily oral extended-release hydromorphone.

被引:0
|
作者
Swanton, R [1 ]
Buckley, B [1 ]
机构
[1] Purdue Pharma LP, Stamford, CT 06901 USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
75
引用
收藏
页码:1068 / 1068
页数:1
相关论文
共 50 条
  • [21] Development and Optimization of Once-Daily Extended-Release Formulations of Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    NEUROLOGY, 2011, 76 (09) : A50 - A50
  • [22] Once-daily extended-release levetiracetam reduces seizure frequency
    Nature Clinical Practice Neurology, 2009, 5 (2): : 63 - 63
  • [23] Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain
    Richarz, Ute
    Waechter, Sandra
    Sabatowski, Rainer
    Szczepanski, Leszek
    Binsfeld, Heinrich
    PAIN PRACTICE, 2013, 13 (01) : 30 - 40
  • [24] Long-term efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol
    Weinstein, Steven F.
    Andrews, Charles P.
    Shah, Shailen R.
    Chylack, Leo T., Jr.
    Tankelevich, Alexander
    Ding, Yu
    Tantry, Sudeesh K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2014, 35 (04) : 323 - 331
  • [25] Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia
    Kashyap, ML
    McGovern, ME
    Berra, K
    Guyton, JR
    Kwiterovich, PO
    Harper, WL
    Toth, PD
    Favrot, LK
    Kerzner, B
    Nash, SD
    Bays, HE
    Simmons, PD
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (06): : 672 - 678
  • [26] Long-term safety and efficacy of antihypertensive therapy with valsartan 320 mg once-daily
    Asmar, R.
    Mengden, T.
    Brudi, P.
    Kandra, A.
    Di Giovanni, R.
    Parati, G.
    JOURNAL OF HYPERTENSION, 2006, 24 : S19 - S20
  • [27] Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain
    Broglio, Kathleen
    Pergolizzi, Joseph
    Kowalski, Maribeth
    Lynch, Shau Yu
    He, Ellie
    Wen, Warren
    PAIN PRACTICE, 2017, 17 (03) : 382 - 391
  • [29] Design and in vitro evaluation of an extended-release matrix tablet for once-daily oral administration of oxybutynin
    Zambito, Y
    Baggiani, A
    Carelli, V
    Serafini, MF
    Di Colo, G
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2005, 15 (05) : 397 - 402
  • [30] Efficacy and Safety of Once-Daily Extended-Release Centanafadine for the Treatment of ADHD in Children Aged 6-12 Years
    Ward, C. L.
    Jin, N.
    Turkoglu, O.
    Skubiak, T.
    Childress, A.
    Mattingly, G.
    van Stralen, J.
    ANNALS OF NEUROLOGY, 2025, 96 : S93 - S93